Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 816-146-0 | CAS number: 1016788-34-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 2012
- Reliability:
- 1 (reliable without restriction)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- Official journal of the European union dated august, 24'h, 2009
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ECVAM protocol
- Version / remarks:
- November 5th, 2008
- Deviations:
- no
- GLP compliance:
- yes
- Test system:
- human skin model
- Details on test system:
- Human reconstructed epidermis, SkinEthic model 0.5 cm', maintained according to the supplier instructions.
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- Series definition:
16 microL of the test item diluted at 5 %, as well as the reference items, are tested on three epidermis.
Test protocol:
16 microL ± 0.5 microL of the test item have been deposited with a positive displacement micropipette on the surface of the epidermis and a 7.5 mm diameter nylon mesh is gently applied on the surface of the
epidermis with tweezers.
16 microL ± 0.5 microL of reference item are deposited with a micropipette positive displacement on the surface of the tissue. A 7.5 mm diameter nylon mesh is gently applied on the surface of the epidermis in with
tweezers. - Duration of treatment / exposure:
- The epidermis are incubated in 0.3 ml of maintenance medium (24 wells plate) at room temperature for 42 minutes ± 1 minute.
- Duration of post-treatment incubation (if applicable):
- Nylon meshes are removed and the epidermis are rinsed with 25 ml of PBS by epidemlis (25 times 1 ml using a dispenser). The residual PBS is eliminated on absorbent paper. If necessary the epidermis
can be gently swept with a cotton tip. The epidermis are incubated in 2 ml of growth medium in 6 wells plate at 37 °C, 5% CO, for 42 hours ± 1 hour.
All epidermis (living and dead) are incubated in 0.3 ml of maintenance medium at 1 mg/ml MIT in 24 well plate.
After 3 hours ± 5 minutes incubation at 37°C, 5% CO2 outside of inserts is rinsed with1I to 2 ml of PBS.
Extraction is performed by placing the epidermis into wells filled with 0.8 ml of isopropanol and covered with 0.7 ml isopropanol for 2 hours ± 5 minutes under gentle agitation protected from light.
The absorbance is measured in triplicat on 200 microL extract in 96-wells plates. Absorbances are measured at 540 nm against a blank consisting with isopropanol. - Number of replicates:
- 3 replicates for test item, 3 replicates for positive control and 3 replicates for negative control
- Irritation / corrosion parameter:
- % tissue viability
- Run / experiment:
- Tissue Viability (%)
- Value:
- ca. 100
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In accordance with the Regulation EC No. 127212008 on classification, labelling and packaging of substances and mixtures, the test item must not be classified.
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 2012
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Assess on 10 volunteers the irritant potential of the studied test item after its unique application, maintained for 48 hours in contact with the skin, with the help of a semi-occlusive patch.
- GLP compliance:
- no
- Remarks:
- Patch test
- Species:
- other: Human
- Details on test animals or test system and environmental conditions:
- 11 volunteers of the female or male sex from 18 to 65 years of age, with a normal skin, without any dermatological lesion on the experimental area, should be included in the study.
- Type of coverage:
- semiocclusive
- Preparation of test site:
- other: semi-occlusive patch
- Vehicle:
- not specified
- Amount / concentration applied:
- Single application of 160 mg of the studied test item diluted at 5 %, on the external face of the arm, maintained for 48 hours in contact with the skin, with the help of a semi-occlusive patch.
- Duration of treatment / exposure:
- 48 hours in contact with the skin, with the help of a semi-occlusive patch.
- Observation period:
- 22/04/2012 to 24/05/2012
- Number of animals:
- 11 volunteers of the female or male sex from 18 to 65 years of age, with a normal skin, without any dermatological lesion on the experimental area, should be included in the study.
- Details on study design:
- The clinical quotation is made 30 minutes after the patch removal and takes in account the erythema, the papules, the vesicles and the blisters. According to their intensity, the quotation is spread out from 0 to 3. The total sum of the scores, divided by the number of volunteers, defines the mean irritation index (M.I.I.), which allows to classify arbitrarily the test item into “non irritant, slightly irritant, moderately irritant, very irritant and severely irritant”.
M.I.I. =< 0.20 Non irritant
0.20 < M.I.I. =< 0.50 Slightly irritant
0.50 < M.I.I. =< 2 Moderately irritant
2 < M.I.I. =< 3 Very irritant - Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 48 h
- Score:
- 0
- Max. score:
- 0
- Reversibility:
- other: not applicable
- Remarks on result:
- no indication of irritation
- Irritant / corrosive response data:
- 11 volunteers have been included and analyzed. The individual scores of product are 0.00 for the 11 volunteers.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test item, applied diluted at 5 %, can be considered as non irritant after an application with the help of a semi-occlusive patch for 48 consecutive hours on 11 volunteers.
Referenceopen allclose all
ASSESMENT OF VIABILITY | CONCLUSION | |||||
Abs. | mean | Standard deviation | Viability % | |||
Negative control PBS |
Ep.1 Ep.2 Ep.3 |
1.904 1.894 1.892 1.951 1.946 1.905 1.778 2.124 1.777 |
1.908 | 0.103 | 100% | Non Irritant |
Positive control SDS 5% |
Ep.1 Ep.2 Ep.3 |
0.020 0.020 0.018 0.021 0.021 0.019 0.022 0.022 0.020 |
0.020 |
0.001 |
1.1% |
Irritant |
Test item |
Ep.1 Ep.2 Ep.3 |
2.160 2.148 2.108 1.862 1.907 1.971 1.707 1.680 1.620 |
1.907 |
0.207 |
100% |
Non Irritant |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- March 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Qualifier:
- according to guideline
- Guideline:
- other: HET-CAM, in accordance with the protocol proposed in the Official Journal of the Republic of France (#300) dated 26 December 1996
- Deviations:
- no
- GLP compliance:
- yes
- Strain:
- other: Hen's eegs (White Leghorn)
- Details on test animals or tissues and environmental conditions:
- Temperature: 37 ºC
- Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- Test system:
Fertilized hen egg (White Leghorn strain) weight from 50 to 65 g at receipt.
Reference items:
-Negative control: Lauryl Sulfo BetaYne (LSB) - CAS number: 14933-08-5 solution at 0.05 % in physiological serum
- Positive control: Lauryl Sulfo BetaYne (LSB) - CAS number: 14933-08-5 solution at 3.2 and 0.4 % in physiological serum
Series definition:
The test item diluted at 5 % is tested on four eggs (300 microL per egg). The reference items are tested in each analysis on two eggs (300 microL). - Duration of treatment / exposure:
- 300 microL of the warmed test item (undiluted or diluted) are carefully placed on the CAM with a pipette and the time clock is started. After contact for 20 seconds the membrane is rinsed with 5 ml of physiological saline at 37°C avoiding any violent splashing. The rinse liquid is removed by tilting the egg.
- Duration of post- treatment incubation (in vitro):
- Any irritant effects are observed for 5 minutes. The time interval when each effect appears (hyperaemia, haemorrhage, coagulation) is recorded by the all or nothing law. The presence and not the severity of the effect is recorded.
- Number of animals or in vitro replicates:
- Test item tested on four eggs, the reference items are tested in each analysis on two eggs.
- Details on study design:
- The principle of the method is based on the observation of the irritant effects (hyperaemia, haemorrhage, coagulation) which may occur within five minutes after placing a test item onto the chorio-allantoic
membrane (CAM) of an embryonic hen egg on the tenth day of incubation.
A score is established from the presence (or absence) of these effects and the time when they appear.
The mean score obtained from four eggs is used to classify the substance into four categories of irritant potential.
Test protocol:
The different stages are performed rapidly under suffic ient lighting not emitting heat. Drying of the CAM must be avoided (if drying occurs maintain the humidity level by spraying).
The egg is placed veltically on a SUppOlt (air pocket upwards).
The shell is cracked at the level of the air pocket and then removed to the level of the shell membrane.
Eggs which do not have a live hen embryo are removed.
The released surface is moistened with physiological saline solution warmed to 37°C and the solution is removed by tilting the egg.
The shell membrane is delicately detached with tweezers and then removed in order to uncover the underlying CAM. Any egg with a defective CAM or traces of haemorrhage is removed. The MCA
integrity is recorded for every egg on scores sheet at the time of the test.
300 !ll of the warmed test item (undiluted or diluted) are carefully placed on the CAM with a pipette and the time clock is started. After contact for 20 seconds the membrane is rinsed with 5 ml of
physiological saline at 37°C avoiding any violent splashing. The rinse liquid is removed by tilting the egg.
At the end of the test, eggs receive a lethal injection of 0.2 ml20 mglml pentobarbital.
Reading procedure:
Any irritant effects are observed for 5 minutes. The time interval when each effect appears (hyperaemia, haemorrhage, coagulation) is recorded by the all or nothing law. The presence and not
the severity of the effect is recorded.
Hyperaemia or injection: Capillaries which were invis ible before adding the substance become visible whereas capillaries which were already visible dilate and become redder. This phenomenon
may affect large diameter vessels.
Haemorrhage: Release of blood escaping from the vessels and or capillaries may take on different appearances, particularly « cauliflower» patches, diffuse sheet, or punctate (the blood escapes
intermittently at di fferent places in the membrane).
It must be noted that:
Haemorrhage may take on a transient appearance: this must nevertheless by counted.
Masked hyperaemia must be counted if massive haemorrhage occurs during the first 30 seconds.
Coagulation, opacity andlor thrombosis:
Opacity: opalescent sheet or direct opacification of part or all of the membrane (take care that this effect is not due to the physico-chemical properties of the substance in aqueous medium, formation of a colloid or precipitate etc.).
Thrombosis: discontinuation of blood flow producing a segmented appearance of the vessels (alternating areas of strangulation more or less dark turgescent areas). Changes occurring in the capillaries are not counted. - Irritation parameter:
- other: evaluation score
- Run / experiment:
- Mean score
- Value:
- ca. 0
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- Same results found for each egg (total number of eggs: 4), details:
Hyperanemia: Notation: 0 , Score: 0
Haemorrhage: Notation: 0, Score:0
Opacity: Notation 0 , Score 0
Subsequently, Score for each egg is 0, and Mean score (4 eggs) is 0.
Control: Lauryl sulfobetaïne
At 3.2% (positive control), score on 2 eggs: 17 (Irritant)
At 0.4% (positive control), score on 2 eggs: 10 (Moderately irritant or Irritant)
At 0.05% (negative control), score on 2 eggs: 0 (Practically non-irritant or Slightly irritant)
Results found for the reference items allow to validate the test. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the retained experimental conditions, the irritant potential of the test item Acetylglycyl-beta-alanine tested diluted at 5 %, may be classified as practically non irritant according to the adopted scale.
Reference
An evaluation score is assigned to each phenomenon according to its occurrence time:
Scores according to the time:
Time
Effect T < 30s 30s<T<2min 2<1'<5min
Hyperaemia 5 3 1
Haemorrhage 7 5 3
Coagulation, opacity and/or thrombosis 9 7 5
The score for each egg is the sum of each phenomenon scores. The test item rating is the arithmetic mean, rounded to two decimal points, of the scores obtained for all eggs (maximum rating 21).
The test item irritation potential (pure or dilute) is given by the following scale:
Rating (N) Classification
N < 1 Practically non irritant
1 =< N<5 Slightly irritant
5 =< N <9 Moderately irritant
N >9 Irritant
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
An in vitro skin irritation study on human reconstructed epidermis (SkinEthic model, OECD guideline 439) and a 48 hours insult patch test were performed.
Under the retained experimental conditions and according to the criteria for classification, packaging and labelling of dangerous subsatances and preparations in accordance with EE derectives 657/548, 2001/59 and 99/45 /, the test item diluted at 5% can be considered as non irritant, and must not be classifed.
To evaluate the eye irritation potential of the substance a HET-CAM test (2009) has been done. According to the score for this test method the substance has been classified as " practically non irritant".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.